REPORT DETAILS AND FEATURES
This report provides patient adherence strategies, industry trends, organizational structure, staffing, and budgets supporting patient compliance initiatives. Life science companies rely on patient adherence strategies to reach a broad range of healthcare consumers, increase revenue and improve patient health outcomes.
- Number of Chapters: 4
- Number of Graphics: 98 + 5 Team Profiles
- Number of Pages: 176
Data have been split by company type:
- Top 10
- Top 50
Scope of responsibility:
- Other (therapeutic area, single brand, business unit, etc.)
Data have been split by team region:
- EU & Can
Profile Highlights and Content:
- Team and Brand Background
- Company size and team region/market
- Team age and scope of responsibility
- Functional oversight
- Brand therapeutic area, annual sales revenue and market
- Percentage of annual revenue lost through patient non-adherence
- Percentage of annual revenue retained through adherence efforts
- Patient Adherence Staffing
- In-house and outsourced FTEs contributed from dedicated patient adherence groups as well as multiple crossfunctional teams
- Expected increase in in-house and outsourced FTEs for dedicated teams and total patient adherence staffing
- Adherence Budget Allocation
- Total brand adherence budget from 2014-2017, where available
- Percentage of budget outsourced
- Percentage of budget dedicated to specific initiative channels and expenses
- Patient organizations
- Patient access
- Salaries and overhead
Top Reasons to Buy This Patient Adherence Program Planning Report
Anticipate increasing patient adherence program budgets for digital patient compliance activities: Companies fund various initiative types to develop a well-rounded patient adherence program strategy. Initiatives can span multiple direct-to-user channels, including digital, mobile and print media. This report discusses how some groups work with patient organizations to provide support and encourage compliance among end users. Additionally, some initiatives offer rebates or financial assistance so that patients can more easily fill their prescriptions.
Involve multiple internal functions in patient adherence program initiatives and planning: To implement patient adherence program activities, companies consider product labeling, reimbursement, side effects disclosures and other aspects relating to the patient experience. Involving input from several internal life science team functions brings knowledge and different perspectives to these initiatives. The study shows how to allocate resources to successfully conduct these activities.
Select patient adherence vendors based on experience levels, reputation and understanding of target populations: Life science companies that do not have the internal resources needed to develop and implement patient adherence initiatives turn to experienced vendors. Patient Adherence discusses qualifications, knowledge bases, therapeutic area knowledge and innovation levels that life science companies consider when outsourcing these objectives.
The following is an excerpt from Chapter 3, Section 1, Patient Adherence Initiative Goals.
Patient Adherence Strategies: Preferred Initiative Design
The channels that surveyed teams use to accomplish their adherence goals also vary. Life science teams may develop disease management and patient counseling programs. Patient adherence teams may also create online resources such as blogs, community discussions and monthly email newsletters. Still other teams may take advantage of newer technologies to encourage patients to remain adherent. As an example, companies like Vitality have created prescription bottles with chips in them that track refills and send automatic reminders to patients.9 To a lesser extent, life science teams may develop gamification structures to promote patient engagement levels.
Determining best-fit initiative channels often requires companies to involve multiple internal and external audiences. Together, industry groups can work to understand the needs of the individual patient groups they support and develop personalized adherence resources. As an example, different patient audiences may necessitate different engagement strategies. Some patients may be more responsive to a phone call reminder, while others may prefer that companies send an SMS reminder message instead. Email may also be a viable channel. However, electronic reminders may get lost in the countless other daily communications that patients receive. Alternatively, patients may not check their email frequently enough to benefit from consistent reminder messages.
To identify patient groups’ preferred communication channels, life science teams may need to undertake a mixture of market research and pilot programs. A Cognizant white paper highlighted one US-based pharmacy benefits manager (PBM)’s usage of a statistical, predictive model.10 This model helped the company to not only predict patient adherence rates, but also to select best-fit adherence options based on previously identified patient behaviors.
Examples of companies that have participated in this study: